BioSpace News Archive

Business

Reports: BMS Hematology Head Out After Liso-Cel and CVR Failure

Nadim Ahmed, president of hematology at BMS, is leaving the company to, according to “pursue other opportunities.”

January 15, 2021
·
2 min read
·
Alex Keown
Drug Development

Clinical Catch-Up: January 11-15

The year is starting to pick up in terms of clinical trial announcements. Here’s a look at last week’s news.

January 15, 2021
·
4 min read
·
Mark Terry
Drug Development

Umbilical Cord Stem Cells Show Promise as COVID-19 Therapy

Mesenchymal stem cells derived from umbilical cord tissue could help treat ARDS in COVID-19 patients, according to results of a Phase I/IIa clinical trial published by University of Miami researchers.

January 15, 2021
·
2 min read
·
Mark Zipkin
Cell and Gene Therapies Shatter Prior Records, with Continued Growth Expected

Janet Lambert, CEO of the Alliance for Regenerative Medicine (ARM), painted a rosy picture despite a few challenges at the 2021 Cell & Gene State of the Industry Briefing during this year’s Biotech Showcase, held virtually January 11-15.

January 15, 2021
·
5 min read
·
Gail Dutton
Final Highlights from the 2021 J.P. Morgan Healthcare Conference

As the 2021 virtual JP Morgan Healthcare Conference wrapped up, there was still news from companies regarding their deals, pipeline and regulatory updates. Here’s a look.

January 15, 2021
·
4 min read
·
Mark Terry
Policy

COVID-19 Updates: New Strains in the U.S., Increased Federal Response to Pandemic

Although there are now two authorized vaccines against COVID-19 available in the United States and a third likely on the way with Johnson & Johnson’s candidate, the nation and world are nowhere near being done with the novel coronavirus, especially with new, more contagious variants now circulating.

January 15, 2021
·
4 min read
·
Alex Keown
Business

Seattle Startup Chases Alzheimer’s with $23 Million Series A

Seattle startup AltPep targets amyloid deposits to treat Alzheimer’s Disease.

January 15, 2021
·
2 min read
·
Kate Goodwin
Deals

Thermo Fisher Takes Deep Dive into Cell and Gene Therapy with Viral Vector Business Buy

Thermo Fisher Scientific announced the completion of Henogen SA, Groupe Novasep SAS’s viral vector manufacturing business in Belgium. The deal was for €725 million in cash.

January 15, 2021
·
3 min read
·
Mark Terry
Business

180 Life Sciences Poised to Break Ground with Anti-TNF Program

Despite a storied career in drug design that has spanned multiple decades, James Woody believes there is still a significant amount of work left to be accomplished with the development of tumor necrosis factor inhibitor biologics.

January 15, 2021
·
4 min read
·
Alex Keown
FDA

FDA Approves Pfizer Med for Rare Form of Pediatric Non-Hodgkin Lymphoma

The U.S. FDA approved Pfizer’s Xalkori (crizotinib) for pediatric patients one year of age and older and young adults with relapsed or refractory, systemic anaplastic large cell lymphoma that is anaplastic lymphoma kinase (ALK)-positive.

January 15, 2021
·
3 min read
·
Mark Terry